Cargando…
Forecasting of the efficiency of monoclonal therapy in the treatment of CoViD-19 induced by the Omicron variant of SARS-CoV2
On November 26, 2021, the World Health Organization (WHO) announced a new variant of concern of SARS-CoV2 called Omicron. This variant has biological–functional characteristics such as to make it much faster in the infectious process so as to show an even more intense spread. Although many data are...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881325/ https://www.ncbi.nlm.nih.gov/pubmed/35251917 http://dx.doi.org/10.1016/j.rinp.2022.105300 |